SCHEMBL6330278

SCHEMBL6330278

CC(C)(C)N(O[Si](C)(C)C(C)(C)C)c1ccc(C(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
SRD5A2 P31213 3/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RXRA P19793 2/20 0.35
RXRB P28702 2/20 0.35
RXRG P48443 2/20 0.35
RARB P10826 1/20 0.35
RARG P13631 1/20 0.35
NR4A2 P43354 1/20 0.33
HCAR3 P49019 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10440021 0.89 HPGD (0.43) HPGDNPC1SRD5A2ALDH1A1
SCHEMBL15716910 0.76 KDM4E (0.31) NPC1
SCHEMBL6332343 0.75 NPC1 (0.57) KMT2AMEN1NPC1TP53TSHR
SCHEMBL6330529 0.74 RAB9A (0.55) HPGDKMT2AMEN1NPC1TP53
SCHEMBL6542930 0.71 CA1 (0.52) HPGDKMT2ASRD5A2TP53TSHR
SCHEMBL4346296 0.71 NR1H2 (0.41) HPGDKMT2AMEN1NPC1POLB
SCHEMBL9699015 0.70 TSHR (0.52) HPGDKMT2AMEN1NPC1POLB
SCHEMBL16730046 0.69 NPC1 (0.52) HPGDKMT2AMEN1NPC1POLB
SCHEMBL3722014 0.68 RXRA (0.51) HPGDNPC1POLBALDH1A1SMN1; SMN2
SCHEMBL1583011 0.66 HPGD (0.54) HPGDKMT2AMEN1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949654-B2 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2005-09-27 US disclosed
US-20030225087-A1 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2003-12-04 US disclosed
WO-2003010153-A1 N-ALKYL-N-PHENYLHYDROXYLAMINE COMPOUNDS CONTAINING METAL CHELATING GROUPS, THEIR PREPARATION AND THEIR THERAPEUTIC USES SAMSUNG ELECTRONICS CO. LTD. (KR) 2003-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225087-A1 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SOD1, LPO, BAD HPGD 730/4885KMT2A 2089/4885MEN1 4263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.